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We investigated the diagnostic yield for systematic 12-core transrectal prostate needle biopsies.
Subjects were 56 prostatic cancer patients who were diagnosed with transrectal ultrasound-guided 12 core
prostate needle biopsies and who underwent open retropubic radical prostatectomy. Pathological ﬁndings
were compared between needle biopsy specimens and total prostatectomy specimens in terms of the presence
or absence of cancer foci. For the comparison, the prostate was divided into 5 regions : the apical, middle,
basal, far lateral and transitional regions. Then, based on the pathological ﬁndings of the biopsies, the
sensitivity, speciﬁcity, positive predictive value and negative predictive value were calculated for each region.
As a result, the sensitivity and the speciﬁcity in the transitional region tended to be lower than in other
regions, and six of ten false positive lesions were located in the transitional region on the biopsy specimens.
Also, the negative predictive value tended to be lower in the apical and far lateral regions. In conclusion,
thorough punctures in the apical, transitional, and far lateral regions of the prostate at the systematic
transrectal biopsy were paramount important for improving the detection of cancer foci in these regions.
(Hinyokika Kiyo 61 : 235-239, 2015)
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Fig. 1. Schematic illustration of 12 biopsy sites in this study.
Table 1. Patient characteristics
n 56
Age (range) (mean±SD) 67.2±5.5
Initial PSA (ng/ml) (mean±SD) 13.4±12.2
Prostate volume (ml) (mean±SD) 24.8±10.0
DRE Positive : 15, negative : 41
cT classiﬁcation
cT1c : 34, cT2a : 11,
cT2b : 5, cT2c : 2, cT3a :
3, cT3b : 1
pT classiﬁcation (n) pT2 : 30, pT3 : 26
Gleason score 6 : 30→21
(Biopsy→prostatectomy, n) 7 : 18→21, 8≦ : 8→14
DRE : Digital rectal examination.
Table 2. Detection rate of cancer foci from biopsy
specimen and prostatectomy specimen in
each region
Zone
PBx, ％ RRP, ％
(R) (L) (R) (L)
Apex 41 (23/56) 50 (28/56) 54 (30/56) 60 (33/56)
Middle 41 (23/56) 45 (25/56) 41 (23/56) 45 (25/56)
Base 39 (22/56) 36 (20/56) 38 (21-56) 36 (20/56)
Far leteral 38 (21/56) 46 (26/56) 43 (24/56) 54 (30/56)
Tranzition 29 (16/56) 36 (21/56) 36 (20/56) 32 (18/56)





















対象の患者背景を Table 1 に示した． 5 領域×2
（両側）×56症例＝560領域において生検と全摘標本の
癌陽性率を Table 2 に示した．生検，全摘標本ともに
尖部，外側辺縁部，中部，底部，移行部の順に陽性率
が高値であった． 5区域に分類された生検部位別の感





についての腫瘍径を Table 4 に示した．移行領域にお
ける腫瘍径の中央値は 17.5 mm，辺縁領域における








刺しえたと仮定した状況では，腫瘍径が 5 mm 未満と
小さく生検で捉えられなかったと考えられる病変が
19％（3/16），5 mm 以上の前立腺腹側の病変が19％
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Table 3. Sensitivity, speciﬁcity, positive predictive value, negative predictive value in location assessment








































PBx : prostate biopsy, RRP : retropubic radical prostatectony, ※ : p＜0.01, ※※ : p＜0.05 (Fischer’s test).
Table 4. Tumor diameter (mm) in peripheral and
tranzitional zones
Zone n Mean Median Min Max p※
Peripheral 94 12.7 10 1 45
NS
Tranzition 12 15.4 17.5 0.8 33
Min : minister, Max : maximum, ※ : t test, NS : not signiﬁcant.
Table 5. Possible causes of false negative results in
each region
Zone n Possible causes (n)
Apex 5 Small lesion 2, different region 3
Middle 2 Anterior side 1, both anterior side and smalllesion 1
Base 0
Far lateral 4 Anterior side 1, different region 3
Tranzition 5 Anterior side 1, small lesion 1, both anteriorside and small lesion 1, different region 2
Small lesion : Less than diameter 5 mm in prostatectomy
specimens, Different region : Biopsy from a different region,
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Fig. 2. Schematic illustration of a needle tract under
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